Marble Harbor Investment Counsel, LLC Bristol Myers Squibb CO Transaction History
Marble Harbor Investment Counsel, LLC
- $826 Million
- Q2 2024
A detailed history of Marble Harbor Investment Counsel, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Marble Harbor Investment Counsel, LLC holds 10,743 shares of BMY stock, worth $564,007. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,743
Previous 11,893
9.67%
Holding current value
$564,007
Previous $644,000
30.75%
% of portfolio
0.05%
Previous 0.08%
Shares
18 transactions
Others Institutions Holding BMY
# of Institutions
2,435Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$9.79 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.33 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.8 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.92 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.1 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $112B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...